Predictive Testing for Tumor Predisposition Syndromes in Pediatric Relatives: An Asian Experience
Sign Up to like & getrecommendations! Published in 2020 at "Frontiers in Pediatrics"
DOI: 10.3389/fped.2020.568528
Abstract: Approximately 10% of pediatric cancer patients possess germline pathogenic/likely pathogenic variants (PV/LPV) in known tumor predisposition genes. Predictive testing is the optimal approach to identify asymptomatic at-risk relatives to guide gene-directed surveillance for early cancer… read more here.
Keywords: predictive testing; tumor predisposition; pediatric fdrs;